Showing results (411-420 of 558) with videos related to
Sort By:
Pageof 56
The Clinical Respiratory Journal|August 2, 2011
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung diseaseMaria De Santis, Silvia Laura Bosello, Giusy Peluso, et al.European Urology|February 27, 2017
Changing Current Practice in Urology: Improving Guideline Development and Implementation Through Stakeholder EngagementSara J MacLennan, Steven MacLennan, Axel Bex, et al.Hepatology (Baltimore, Md.)|October 28, 2003
Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacteriumCarlo Selmi, David L Balkwill, Pietro Invernizzi, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
X chromosome monosomy: a common mechanism for autoimmune diseasesPietro Invernizzi, Monica Miozzo, Carlo Selmi, et al.Hepatology (Baltimore, Md.)|November 22, 2007
Quality of life and everyday activities in patients with primary biliary cirrhosisCarlo Selmi, M Eric Gershwin, Keith D Lindor, et al.American Journal of Preventive Cardiology|January 1, 2026
The risk of cardiovascular death in systemic immune-mediated diseases: A systematic review and meta-analysisStefano Figliozzi, Thanakorn Rojanathagoon, Spyridoula Karogianni, et al.Frontiers in Immunology|October 1, 2021
Characterization of Organ-Specific Regulatory B Cells Using Single-Cell RNA SequencingSi-Yu Yang, Jie Long, Meng-Xing Huang, et al.Annals of the Rheumatic Diseases|June 24, 2021
Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study resultsJosef S Smolen, Stefan Siebert, Tatiana V Korotaeva, et al.Annals of the New York Academy of Sciences|October 4, 2007
X monosomy in female systemic lupus erythematosusPietro Invernizzi, Monica Miozzo, Sabine Oertelt-Prigione, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987Joaquim Bellmunt, Hans von der Maase, Graham M Mead, et al.Pageof 56